¿Û¿Û´«Ã½

Time to back this once-recovery stock

Simon Thompson: The company is delivering double-digit sales growth and offers a strong earnings recovery potential

This top-performing small-cap fund will keep on delivering

Simon Thompson: The largest holding has received regulatory approval for a medical device that could revolutionise treatment

New funding could be a game-changer for this energy stock

Simon Thompson: A £100mn facility to finance energy-efficient projects puts the business on a solid footing

Don’t miss out on this tender offer

Simon Thompson: A software provider is redeeming almost 75 per cent of its shares and is looking to de-list from Aim

A mining trust whose re-rating is far from over

Simon Thompson: It has sold a royalty for four times book value and could actively reduce the share price discount

Another guidance downgrade – are these shares worth holding?

Simon Thompson: Growing uncertainty around tariffs and consumer confidence has led to lower order intake

This fintech fund is primed to deliver

Simon Thompson: The shares are priced on almost half NAV even though valuations are recovering

Investors are undervaluing this manufacturer’s prospects

Simon Thompson: The shares trade on a forward PE ratio of 10, and there is scope for acquisitions, too

A game-changing new strategy will boost this healthcare stock

Simon Thompson: Smart acquisitions and sales of low-margin operations should boost this lowly rated and debt-free company

An earnings upgrade cycle that will keep on going

Simon Thompson: This stock has posted another earnings beat and prompted analyst upgrades